4.6 Article

Temporal trends of the prevalence and incidence of atrial fibrillation and stroke among Asian patients with hypertrophic cardiomyopathy: A nationwide population-based study

Journal

INTERNATIONAL JOURNAL OF CARDIOLOGY
Volume 273, Issue -, Pages 130-135

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.ijcard.2018.08.038

Keywords

Hypertrophic cardiomyopathy; Atrial fibrillation; Stroke; Epidemiology

Funding

  1. National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2014R1A1A2A16055218]
  2. Technology Innovation Program or Industrial Strategic Technology Development Program - Ministry of Trade, Industry and Energy (MOTIE, Sejong, Korea) [10052668]

Ask authors/readers for more resources

Background: Atrial fibrillation (AF) and stroke are common in hypertrophic cardiomyopathy (HCM ). We aimed to determine the prevalence and incidence of AF and stroke in patients with HCM during a 10-year period. Methods: Using the Korean National Health Insurance Services database, we identified patients diagnosed with HCM from the entire Korean population between 2005 and 2015. The annual prevalence and incidence of AF and stroke in HCM patients were estimated. Results: The prevalence of AF in HCM patients has gradually increased to 1.6-fold from 13.4% in 2005 to 20.9% in 2015. The incidence of AF ranged from 4.1 to 5.5%, a similar trend was observed for each year in HCM patients. The prevalence of stroke in HCM patients was approximately 10%, while that in HCM patients with AF was about 20%. During 8741 person-years, AF-related stroke occurred in 257 subjects among 2309 HCM patients with new-onset AF. The overall incidence rate of AF-associated stroke was 2.94 per 100 person-years. In subgroup analysis, the incidence rate of AF-associated stroke was 1.49 per 100 person-years in the under 45 year-old group and 1.48 per 100 person-years in the group with CHA(2)DS(2)VASc score of 0 or 1 point in HCM patients. Conclusions: The prevalence of AF in HCM patients gradually increased over 10 years. The annual risk of AF-associated stroke in HCM was over 1% even in younger patients and those with CHA(2)DS(2)VASc score of 0 or 1 point, which provide evidence to support the prevention of stroke in HCM patients with AF. (C) 2018 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available